Literature DB >> 26027726

Cdk5 controls lymphatic vessel development and function by phosphorylation of Foxc2.

Johanna Liebl1, Siwei Zhang1, Markus Moser2, Yan Agalarov3, Cansaran Saygili Demir3, Bianca Hager1, James A Bibb4, Ralf H Adams5, Friedemann Kiefer6, Naoyuki Miura7, Tatiana V Petrova8, Angelika M Vollmar1, Stefan Zahler1.   

Abstract

The lymphatic system maintains tissue fluid balance, and dysfunction of lymphatic vessels and valves causes human lymphedema syndromes. Yet, our knowledge of the molecular mechanisms underlying lymphatic vessel development is still limited. Here, we show that cyclin-dependent kinase 5 (Cdk5) is an essential regulator of lymphatic vessel development. Endothelial-specific Cdk5 knockdown causes congenital lymphatic dysfunction and lymphedema due to defective lymphatic vessel patterning and valve formation. We identify the transcription factor Foxc2 as a key substrate of Cdk5 in the lymphatic vasculature, mechanistically linking Cdk5 to lymphatic development and valve morphogenesis. Collectively, our findings show that Cdk5-Foxc2 interaction represents a critical regulator of lymphatic vessel development and the transcriptional network underlying lymphatic vascular remodeling.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26027726     DOI: 10.1038/ncomms8274

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  45 in total

1.  Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation.

Authors:  Pavel Uhrin; Jan Zaujec; Johannes M Breuss; Damla Olcaydu; Peter Chrenek; Hannes Stockinger; Elke Fuertbauer; Markus Moser; Paula Haiko; Reinhard Fässler; Kari Alitalo; Bernd R Binder; Dontscho Kerjaschki
Journal:  Blood       Date:  2010-01-28       Impact factor: 22.113

2.  An unexpected role of semaphorin3a-neuropilin-1 signaling in lymphatic vessel maturation and valve formation.

Authors:  Giorgia Jurisic; Hélène Maby-El Hajjami; Sinem Karaman; Alexandra M Ochsenbein; Annamari Alitalo; Shoib S Siddiqui; Carlos Ochoa Pereira; Tatiana V Petrova; Michael Detmar
Journal:  Circ Res       Date:  2012-06-20       Impact factor: 17.367

3.  The contribution of the Tie2+ lineage to primitive and definitive hematopoietic cells.

Authors:  Yuefeng Tang; Anne Harrington; Xuehui Yang; Robert E Friesel; Lucy Liaw
Journal:  Genesis       Date:  2010-09       Impact factor: 2.487

4.  Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis.

Authors:  Guo Wei; Ruchika Srinivasan; Carmen Z Cantemir-Stone; Sudarshana M Sharma; Ramasamy Santhanam; Michael Weinstein; Natarajan Muthusamy; Albert K Man; Robert G Oshima; Gustavo Leone; Michael C Ostrowski
Journal:  Blood       Date:  2009-05-01       Impact factor: 22.113

5.  Phosphorylation regulates FOXC2-mediated transcription in lymphatic endothelial cells.

Authors:  Konstantin I Ivanov; Yan Agalarov; Leena Valmu; Olga Samuilova; Johanna Liebl; Nawal Houhou; Hélène Maby-El Hajjami; Camilla Norrmén; Muriel Jaquet; Naoyuki Miura; Nadine Zangger; Seppo Ylä-Herttuala; Mauro Delorenzi; Tatiana V Petrova
Journal:  Mol Cell Biol       Date:  2013-07-22       Impact factor: 4.272

Review 6.  Twice switched at birth: cell cycle-independent roles of the "neuron-specific" cyclin-dependent kinase 5 (Cdk5) in non-neuronal cells.

Authors:  Johanna Liebl; Robert Fürst; Angelika M Vollmar; Stefan Zahler
Journal:  Cell Signal       Date:  2011-06-30       Impact factor: 4.315

7.  Truncating mutations in FOXC2 cause multiple lymphedema syndromes.

Authors:  D N Finegold; M A Kimak; E C Lawrence; K L Levinson; E M Cherniske; B R Pober; J W Dunlap; R E Ferrell
Journal:  Hum Mol Genet       Date:  2001-05-15       Impact factor: 6.150

8.  A novel multistep mechanism for initial lymphangiogenesis in mouse embryos based on ultramicroscopy.

Authors:  René Hägerling; Cathrin Pollmann; Martin Andreas; Christian Schmidt; Harri Nurmi; Ralf H Adams; Kari Alitalo; Volker Andresen; Stefan Schulte-Merker; Friedemann Kiefer
Journal:  EMBO J       Date:  2013-01-08       Impact factor: 11.598

9.  Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis.

Authors:  Eleni Bazigou; Sherry Xie; Chun Chen; Anne Weston; Naoyuki Miura; Lydia Sorokin; Ralf Adams; Andrés F Muro; Dean Sheppard; Taija Makinen
Journal:  Dev Cell       Date:  2009-08       Impact factor: 12.270

10.  Trisubstituted pyrazolopyrimidines as novel angiogenesis inhibitors.

Authors:  Sabine B Weitensteiner; Johanna Liebl; Vladimir Krystof; Libor Havlíček; Tomáš Gucký; Miroslav Strnad; Robert Fürst; Angelika M Vollmar; Stefan Zahler
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

View more
  24 in total

1.  Anti-angiogenic effects of novel cyclin-dependent kinase inhibitors with a pyrazolo[4,3-d]pyrimidine scaffold.

Authors:  S Zhang; M Ulrich; A Gromnicka; L Havlíček; V Kryštof; R Jorda; M Strnad; A M Vollmar; S Zahler
Journal:  Br J Pharmacol       Date:  2016-07-24       Impact factor: 8.739

Review 2.  Lymphatic Vessel Network Structure and Physiology.

Authors:  Jerome W Breslin; Ying Yang; Joshua P Scallan; Richard S Sweat; Shaquria P Adderley; Walter L Murfee
Journal:  Compr Physiol       Date:  2018-12-13       Impact factor: 9.090

Review 3.  The Emerging Role of Cdk5 in Cancer.

Authors:  Karine Pozo; James A Bibb
Journal:  Trends Cancer       Date:  2016-10

Review 4.  Oncogenic functions of the FOXC2 transcription factor: a hallmarks of cancer perspective.

Authors:  Kristian M Hargadon; Travis B Goodloe; Nathaniel D Lloyd
Journal:  Cancer Metastasis Rev       Date:  2022-06-14       Impact factor: 9.264

5.  Ileitis-associated tertiary lymphoid organs arise at lymphatic valves and impede mesenteric lymph flow in response to tumor necrosis factor.

Authors:  Rafael S Czepielewski; Emma C Erlich; Emily J Onufer; Shannon Young; Brian T Saunders; Yong-Hyun Han; Mary Wohltmann; Peter L Wang; Ki-Wook Kim; Shashi Kumar; Chyi-Song Hsieh; Joshua P Scallan; Ying Yang; Bernd H Zinselmeyer; Michael J Davis; Gwendalyn J Randolph
Journal:  Immunity       Date:  2021-11-16       Impact factor: 31.745

6.  Low Efficacy of Genetic Tests for the Diagnosis of Primary Lymphedema Prompts Novel Insights into the Underlying Molecular Pathways.

Authors:  Gabriele Bonetti; Stefano Paolacci; Michele Samaja; Paolo Enrico Maltese; Sandro Michelini; Serena Michelini; Silvia Michelini; Maurizio Ricci; Marina Cestari; Astrit Dautaj; Maria Chiara Medori; Matteo Bertelli
Journal:  Int J Mol Sci       Date:  2022-07-03       Impact factor: 6.208

7.  Segregated Foxc2, NFATc1 and Connexin expression at normal developing venous valves, and Connexin-specific differences in the valve phenotypes of Cx37, Cx43, and Cx47 knockout mice.

Authors:  Stephanie J Munger; Xin Geng; R Sathish Srinivasan; Marlys H Witte; David L Paul; Alexander M Simon
Journal:  Dev Biol       Date:  2016-03-04       Impact factor: 3.582

8.  Inhibition of endothelial Cdk5 reduces tumor growth by promoting non-productive angiogenesis.

Authors:  Henriette Merk; Siwei Zhang; Thorsten Lehr; Christoph Müller; Melanie Ulrich; James A Bibb; Ralf H Adams; Franz Bracher; Stefan Zahler; Angelika M Vollmar; Johanna Liebl
Journal:  Oncotarget       Date:  2016-02-02

9.  Cdk5 and Foxc2--a new relationship in the lymphatic vasculature.

Authors:  Johanna Liebl
Journal:  Oncotarget       Date:  2015-09-08

10.  Anti-leukemic effects of the V-ATPase inhibitor Archazolid A.

Authors:  Siwei Zhang; Lina S Schneider; Binje Vick; Michaela Grunert; Irmela Jeremias; Dirk Menche; Rolf Müller; Angelika M Vollmar; Johanna Liebl
Journal:  Oncotarget       Date:  2015-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.